Acute lithium treatment enhances neuropeptide Y gene expression in rat hippocampus

Elyse D. Weiner, Ann Marie Mallat, Demitri F. Papolos, Herbert M. Lachman

Research output: Contribution to journalArticle

31 Citations (Scopus)

Abstract

It has been suggested that the therapeutic action of lithium in affective disorders may be due to its inhibition of signal transduction and second messenger synthesis, in particular of the phosphoinositide (PI) pathway. Yet, previous work in neuronal cell lines indicates that lithium has an enhancing effect on gene expression mediated by protein kinase C, which is activated by the PI pathway. In this report, we have analyzed the effect of lithium on two neuropeptide encoding genes that are regulated by second messenger systems; neuropeptide Y (NPY) and proenkephalin (Enk). We find that acute treatment with lithium, resulting in serum levels that are within the therapeutic range effective in patients with mood disorders, significantly enhances basal expression of the NPY gene in rat hippocampus. In contrast, no effect on Enk expression was detected. This selective effect in a limbic structure supports the hypothesis that gene expression may be an important target of lithium's therapeutic action.

Original languageEnglish (US)
Pages (from-to)209-214
Number of pages6
JournalMolecular Brain Research
Volume12
Issue number1-3
DOIs
StatePublished - 1992

Fingerprint

Neuropeptide Y
Lithium
Hippocampus
Gene Expression
Second Messenger Systems
Phosphatidylinositols
Mood Disorders
Therapeutics
Neuropeptides
Protein Kinase C
Genes
Signal Transduction
Cell Line
Serum

Keywords

  • Glucocorticoid
  • Hippocampus
  • Lithium
  • Manic depression
  • Neuropeptide Y
  • Protein kinase C

ASJC Scopus subject areas

  • Molecular Biology
  • Cellular and Molecular Neuroscience

Cite this

Acute lithium treatment enhances neuropeptide Y gene expression in rat hippocampus. / Weiner, Elyse D.; Mallat, Ann Marie; Papolos, Demitri F.; Lachman, Herbert M.

In: Molecular Brain Research, Vol. 12, No. 1-3, 1992, p. 209-214.

Research output: Contribution to journalArticle

Weiner, Elyse D. ; Mallat, Ann Marie ; Papolos, Demitri F. ; Lachman, Herbert M. / Acute lithium treatment enhances neuropeptide Y gene expression in rat hippocampus. In: Molecular Brain Research. 1992 ; Vol. 12, No. 1-3. pp. 209-214.
@article{07c5e290cd9e44f7b1900351938ed1a3,
title = "Acute lithium treatment enhances neuropeptide Y gene expression in rat hippocampus",
abstract = "It has been suggested that the therapeutic action of lithium in affective disorders may be due to its inhibition of signal transduction and second messenger synthesis, in particular of the phosphoinositide (PI) pathway. Yet, previous work in neuronal cell lines indicates that lithium has an enhancing effect on gene expression mediated by protein kinase C, which is activated by the PI pathway. In this report, we have analyzed the effect of lithium on two neuropeptide encoding genes that are regulated by second messenger systems; neuropeptide Y (NPY) and proenkephalin (Enk). We find that acute treatment with lithium, resulting in serum levels that are within the therapeutic range effective in patients with mood disorders, significantly enhances basal expression of the NPY gene in rat hippocampus. In contrast, no effect on Enk expression was detected. This selective effect in a limbic structure supports the hypothesis that gene expression may be an important target of lithium's therapeutic action.",
keywords = "Glucocorticoid, Hippocampus, Lithium, Manic depression, Neuropeptide Y, Protein kinase C",
author = "Weiner, {Elyse D.} and Mallat, {Ann Marie} and Papolos, {Demitri F.} and Lachman, {Herbert M.}",
year = "1992",
doi = "10.1016/0169-328X(92)90086-Q",
language = "English (US)",
volume = "12",
pages = "209--214",
journal = "Brain Research",
issn = "0006-8993",
publisher = "Elsevier",
number = "1-3",

}

TY - JOUR

T1 - Acute lithium treatment enhances neuropeptide Y gene expression in rat hippocampus

AU - Weiner, Elyse D.

AU - Mallat, Ann Marie

AU - Papolos, Demitri F.

AU - Lachman, Herbert M.

PY - 1992

Y1 - 1992

N2 - It has been suggested that the therapeutic action of lithium in affective disorders may be due to its inhibition of signal transduction and second messenger synthesis, in particular of the phosphoinositide (PI) pathway. Yet, previous work in neuronal cell lines indicates that lithium has an enhancing effect on gene expression mediated by protein kinase C, which is activated by the PI pathway. In this report, we have analyzed the effect of lithium on two neuropeptide encoding genes that are regulated by second messenger systems; neuropeptide Y (NPY) and proenkephalin (Enk). We find that acute treatment with lithium, resulting in serum levels that are within the therapeutic range effective in patients with mood disorders, significantly enhances basal expression of the NPY gene in rat hippocampus. In contrast, no effect on Enk expression was detected. This selective effect in a limbic structure supports the hypothesis that gene expression may be an important target of lithium's therapeutic action.

AB - It has been suggested that the therapeutic action of lithium in affective disorders may be due to its inhibition of signal transduction and second messenger synthesis, in particular of the phosphoinositide (PI) pathway. Yet, previous work in neuronal cell lines indicates that lithium has an enhancing effect on gene expression mediated by protein kinase C, which is activated by the PI pathway. In this report, we have analyzed the effect of lithium on two neuropeptide encoding genes that are regulated by second messenger systems; neuropeptide Y (NPY) and proenkephalin (Enk). We find that acute treatment with lithium, resulting in serum levels that are within the therapeutic range effective in patients with mood disorders, significantly enhances basal expression of the NPY gene in rat hippocampus. In contrast, no effect on Enk expression was detected. This selective effect in a limbic structure supports the hypothesis that gene expression may be an important target of lithium's therapeutic action.

KW - Glucocorticoid

KW - Hippocampus

KW - Lithium

KW - Manic depression

KW - Neuropeptide Y

KW - Protein kinase C

UR - http://www.scopus.com/inward/record.url?scp=0026541659&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0026541659&partnerID=8YFLogxK

U2 - 10.1016/0169-328X(92)90086-Q

DO - 10.1016/0169-328X(92)90086-Q

M3 - Article

VL - 12

SP - 209

EP - 214

JO - Brain Research

JF - Brain Research

SN - 0006-8993

IS - 1-3

ER -